Research Paper Volume 15, Issue 19 pp 10305—10329
The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
Figure 6. This figure provides insights into the connection between risk scores and various clinical attributes. The specific details are as follows: (A) Clinical characteristics are integrated with risk grouping to facilitate an examination of the distribution of clinical attributes and the expression patterns of model genes across distinct risk groups. (B–F) The distribution of age, T-stage, clinical stage, N-stage, and M-stage among LUAD patients in different risk groups is observed and presented as percentages.